Hood River Capital Management LLC Iovance Biotherapeutics, Inc. Transaction History
Hood River Capital Management LLC
- $5.79 Billion
- Q4 2024
A detailed history of Hood River Capital Management LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 8,991,573 shares of IOVA stock, worth $33.7 Million. This represents 1.15% of its overall portfolio holdings.
Number of Shares
8,991,573
Previous 8,144,637
10.4%
Holding current value
$33.7 Million
Previous $76.5 Million
13.0%
% of portfolio
1.15%
Previous 1.42%
Shares
12 transactions
Others Institutions Holding IOVA
# of Institutions
343Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$103 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$91.6 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$82.9 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$79.6 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$45.9 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $592M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...